ArticleBMJ open2026
Trends, patterns and outcomes in hospitalisations for Alzheimer's disease: a 14-year retrospective analysis in Southwest China (2011-2024).
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo analyse temporal trends, clinical outcomes and healthcare costs of Alzheimer's disease (AD)-related hospitalisations in Southwest China over 14 years and identify modifiable risk factors for adverse outcomes.
designRetrospective time-series analysis of electronic health records.
settingA tertiary referral centre in Southwest China (covering Sichuan, Guizhou, Yunnan and Xinjiang provinces); single-centre study.
participants4970 hospitalisations of patients with a confirmed diagnosis of AD (ICD-10: G30) discharged between January 2011 and December 2024, with a mean age of 77.8±0.14 years, and 51.7% were female.
interventionsNot applicable (observational study). PRIMARY AND SECONDARY OUTCOME MEASURES: Primary outcomes were poor hospital outcomes, defined as prolonged length of stay (>14 days), frequent readmissions (≥4 admissions over the study period) and in-hospital mortality. Secondary outcomes included annual trends in hospitalisation rates, total costs and prevalence of comorbidities.
resultsComorbidities (64.75% of admissions, mainly infections and fractures) and admission to non-neurology departments independently increased risks of prolonged stay (OR=5.248, 95% CI 4.287 to 6.425; p<0.001), frequent readmissions (OR=1.735, 95% CI 1.236 to 2.435; p=0.001) and in-hospital mortality (OR=2.176, 95% CI 1.506 to 3.146; p<0.001). Hospitalisations rose annually by 7.65% (95% CI 3.00% to 12.31%; p=0.001) and total costs by 8.32% (p<0.001), yet the composite poor-outcome rate declined from 70% to 50% after 2018 (annual percent change, -6.32%, p=0.004), coinciding with fewer comorbidity-driven admissions and increased neurology department care.
conclusionsComorbidities and non-neurology admissions were associated with increased risks of adverse outcomes in this cohort. The post-2018 temporal improvements coincided with a decline in comorbidity-driven admissions and increased neurology department use. Further prospective studies are needed to confirm these associations.
trial registrationNot applicable (observational study; not registered).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.